Compare FLL & CBUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLL | CBUS |
|---|---|---|
| Founded | 1987 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Agricultural Chemicals |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7M | 69.9M |
| IPO Year | 1993 | 2017 |
| Metric | FLL | CBUS |
|---|---|---|
| Price | $3.03 | $1.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $5.00 | ★ $20.00 |
| AVG Volume (30 Days) | 160.2K | ★ 169.0K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $299,916,000.00 | $3,794,000.00 |
| Revenue This Year | $4.94 | N/A |
| Revenue Next Year | $7.83 | $109.96 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 7.45 | N/A |
| 52 Week Low | $2.25 | $1.09 |
| 52 Week High | $5.59 | $4.24 |
| Indicator | FLL | CBUS |
|---|---|---|
| Relative Strength Index (RSI) | 61.25 | 53.91 |
| Support Level | $2.86 | $1.49 |
| Resistance Level | $3.25 | $1.75 |
| Average True Range (ATR) | 0.18 | 0.14 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 66.15 | 57.14 |
Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.